补充维生素D对代谢综合征的影响: 一项回顾性研究

doi:10.5246/jcps.2023.03.017

中国药学(英文版) ›› 2023, Vol. 32 ›› Issue (3): 200-206.DOI: 10.5246/jcps.2023.03.017

补充维生素D对代谢综合征的影响: 一项回顾性研究

杨婧, 王鑫, 王子惠, 于晓佳, 王华光, 朱莹, 李博宇, 邱爽, 安卓玲^*()

首都医科大学附属北京朝阳医院药事部, 北京 100020

收稿日期:2022-10-15 修回日期:2022-11-20 接受日期:2022-12-26 出版日期:2023-03-31 发布日期:2023-03-30
通讯作者: 安卓玲
作者简介:
+ Tel.: +86-10-85231364, E-mail: 734652507@qq.com

Effect of vitamin D supplementation on metabolic syndrome: a retrospective study

Jing Yang, Xin Wang, Zihui Wang, Xiaojia Yu, Huaguang Wang, Ying Zhu, Boyu Li, Shuang Qiu, Zhuoling An^*()

Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China

Received:2022-10-15 Revised:2022-11-20 Accepted:2022-12-26 Online:2023-03-31 Published:2023-03-30
Contact: Zhuoling An

摘要/Abstract

摘要：

补充维生素D可以改善代谢综合征相关指标。我们的研究希望找出对于25(OH)D水平低的患者, 这种改善是否具有剂量依赖性。我们对2017年1月至2019年6月患有代谢综合征的患者进行了回顾性研究。根据25(OH)D的基本水平分为三组。1组和2组(血清25(OH)D < 20 nmol/L)给予第一周口服维生素D₂ 80 000 IU, 随后3周每周给予维生素D₂ 40 000 IU。3组血清25(OH)D为20–30 nmol/L, 每周给予维生素D₂40 000 IU, 口服4周。采用卡方检验、单因素方差分析和T检验的方法进行分析。结果发现, 共111名患者纳入研究, 平均年龄为62.21 ± 13.35岁(21–89岁), 平均血清25(OH)D为14.67 ± 5.75 nmol/L (4.6–27.5 nmol/L)。在使用维生素D 29.92 ± 2.72天后, 各组血清25(OH)D显著升高(P < 0.05)。收缩压、甘油三酯和低密度脂蛋白胆固醇显著降低(P < 0.05), 而总胆固醇和空腹血糖无明显降低。三组间收缩压、舒张压、总胆固醇、低密度脂蛋白胆固醇、甘油三酯差异无统计学意义(P > 0.05)。增加25(OH)D水平可以减轻他汀类药物引起的疼痛, 尽管他汀类基因的结果表明肌痛的风险很高。综上所述, 补充维生素D对代谢综合征的患者有益, 但尚未发现这种益处与补充维生素D的剂量有关。

关键词: 代谢综合征, 维生素D, 25(OH)D

Abstract:

Vitamin D supplementation can improve metabolic syndrome (MetS)-related indicators. In the present study, we aimed to explore whether this improvement was dose-dependent in patients with low 25(OH)D levels. A retrospective study that recruited MetS patients from January 2017 to June 2019 was undertaken. They were divided into three groups according to the basic level of 25(OH)D. Chi-square test, one-way ANOVA, and T-test were used to examine the differences. A total of 111 patients were included in this study. The average age of them was 62.21 ± 13.35 years (21–89 years), and the mean serum 25(OH)D was 14.67 ± 5.75 nmol/L (4.6–27.5 nmol/L). After 29.92 ± 2.72 d, the serum 25(OH)D of each group was significantly increased (P < 0.05). The SBP, TG, and LDL-C were significantly decreased (P < 0.05), while TC and FBG were unaffected. There was no difference between the three groups (P > 0.05). Increasing the level of 25(OH)D could alleviate the pain caused by statins, even though the results of the statin gene suggested that the risk of myalgia was high. Taken together, vitamin D supplementation was beneficial for patients with MetS, and the benefit was not dose-related.

Key words: Metabolic syndrome, Vitamin D, 25(OH)D

Supporting:

杨婧, 王鑫, 王子惠, 于晓佳, 王华光, 朱莹, 李博宇, 邱爽, 安卓玲. 补充维生素D对代谢综合征的影响: 一项回顾性研究[J]. 中国药学(英文版), 2023, 32(3): 200-206.

Jing Yang, Xin Wang, Zihui Wang, Xiaojia Yu, Huaguang Wang, Ying Zhu, Boyu Li, Shuang Qiu, Zhuoling An. Effect of vitamin D supplementation on metabolic syndrome: a retrospective study[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 200-206.

图/表 3

参考文献 27

[1]	Alberti, K.G.M.M.; Zimmet, P.; Shaw, J.; Group, I.D.F.E.T.F.C. The metabolic syndrome: a new worldwide definition. Lancet. 2005, 366, 1059–1062.
[2]	Anderson, P.J.; Critchley, J.A.; Chan, J.C.; Cockram, C.S.; Lee, Z.S.; Thomas, G.N.; Tomlinson, B. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 1782–1788.
[3]	Carr, D.B.; Utzschneider, K.M.; Hull, R.L.; Kodama, K.; Retzlaff, B.M.; Brunzell, J.D.; Shofer, J.B.; Fish, B.E.; Knopp, R.H.; Kahn, S.E. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004, 53, 2087–2094.
[4]	Sacerdote, A.; Dave, P.; Lokshin, V.; Bahtiyar, G. Type 2 diabetes mellitus, insulin resistance, and vitamin D. Curr. Diab Rep. 2019, 19, 101.
[5]	LeBlanc, E, Chou, R, Zakher, B, Daeges, M, Pappas, M. Screening for vitamin D deficiency: systematic review for the US preventive services task force recommendation [Internet]. Agency Healthc. Res. Quality (US). 2014, 11, 13-05183-EF-1.
[6]	Zhao, G.X.; Ford, E.S.; Li, C.Y. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among US adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care. 2010, 33, 344–347.
[7]	Kim, M.K.; Il Kang, M.; Won Oh, K.; Kwon, H.S.; Lee, J.H.; Lee, W.C.; Yoon, K.H.; Son, H.Y. ORIGINAL ARTICLE: the association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin. Endocrinol. 2010, 73, 330–338.
[8]	Spradley, B.D.; Crowley, K.R.; Tai, C.Y.; Kendall, K.L.; Fukuda, D.H.; Esposito, E.N.; Moon, S.E.; Moon, J.R. Ingesting a pre-workout supplement containing caffeine, B-vitamins, amino acids, creatine, and beta-alanine before exercise delays fatigue while improving reaction time and muscular endurance. Nutr. Metab. (Lond) 2012, 9, 28.
[9]	Wagner, C.L.; McNeil, R.; Hamilton, S.A.; Winkler, J.; Cook, C.R.; Warner, G.; Bivens, B.; Davis, D.J.; Smith, P.G.; Murphy, M.; Shary, J.R.; Hollis, B.W. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol. 2013, 208, 137.e1–137.e13.
[10]	Park, H.Y.; Lim, Y.H.; Kim, J.H.; Bae, S.; Oh, S.Y.; Hong, Y.C. Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: a repeated measure analysis. J. Korean Med. Sci. 2012, 27, 653–660.
[11]	Saneei, P.; Salehi-Abargouei, A.; Esmaillzadeh, A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes. Rev. 2013, 14, 393–404.
[12]	Mirhosseini, N.; Vatanparast, H.; Kimball, S.M. The association between serum 25(OH)D status and blood pressure in participants of a community-based program taking vitamin D supplements. Nutrients. 2017, 9, 1244.
[13]	Del Pinto, R.; Wright, J.T.; Monaco, A.; Pietropaoli, D.; Ferri, C. Vitamin D and blood pressure control among hypertensive adults: results from NHANES 2001-2014. J. Hypertens. 2020, 38, 150–158.
[14]	Ullah, M.I.; Uwaifo, G.I.; Nicholas, W.C.; Koch, C.A. Does vitamin D deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int. J. Endocrinol. 2010, 2010, 579640.
[15]	Chan, R.; Chan, D.; Woo, J.; Ohlsson, C.; Mellström, D.; Kwok, T.; Leung, P. Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. J. Hum. Hypertens. 2012, 26, 20–27.
[16]	Dorjgochoo, T.; Shu, X.; Xiang, Y.B.; Yang, G.; Cai, Q.Y.; Li, H.L.; Ji, B.T.; Cai, H.; Gao, Y.T.; Zheng, W. Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women’s and Men’s Health Studies. Br. J. Nutr. 2012, 108, 449–458.
[17]	Wang, J.H.; Keisala, T.; Solakivi, T.; Minasyan, A.; Kalueff, A.V.; Tuohimaa, P. Serum cholesterol and expression of ApoAI, LXRβ and SREBP₂ in vitamin D receptor knock-out mice. J. Steroid Biochem. Mol. Biol. 2009, 113, 222–226.
[18]	Christensen, R.; Lorenzen, J.K.; Svith, C.R.; Bartels, E.M.; Melanson, E.L.; Saris, W.H.; Tremblay, A.; Astrup, A. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes. Rev. 2009, 10, 475–486.
[19]	Jorde, R.; Grimnes, G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog. Lipid Res. 2011, 50, 303–312.
[20]	Sun, X.M.; Cao, Z.B.; Tanisawa, K.; Ito, T.; Oshima, S.; Ishimi, Y.; Tabata, I.; Higuchi, M. Associations between the serum 25(OH)D concentration and lipid profiles in Japanese men. J. Atheroscler. Thromb. 2015, 22, 355–362.
[21]	Lu, Y.H.; Liu, M.Y.; Pei, Y.; Li, J.; Tian, H.; Cheng, X.L.; Fang, F.S.; Sun, B.R.; Xiao, H.Y.; Li, N.; Miao, X.Y.; Li, C.L. Low levels of serum 25-hydroxyvitamin D and risk of metabolic syndrome in China. Int. J. Clin. Exp. Med. 2015, 8, 13790–13796.
[22]	Mirhosseini, N.; Rainsbury, J.; Kimball, S.M. Vitamin D supplementation, serum 25(OH)D concentrations and cardiovascular disease risk factors: a systematic review and meta-analysis. Front. Cardiovasc. Med. 2018, 5, 87.
[23]	Takiishi, T.; Gysemans, C.; Bouillon, R.; Mathieu, C. Vitamin D and diabetes. Rheum Dis. Clin. North Am. 2012, 38, 179–206.
[24]	Thomas, G.N.; Scragg, R.; Jiang, C.Q.; Chan, W.; Marz, W.; Pilz, S.; Kim, H.C.; Tomlinson, B.; Bosch, J.; Lam, T.H.; Cheung, B.M.Y.; Cheng, K.K. Hyperglycaemia and vitamin D: a systematic overview. Curr. Diabetes Rev. 2012, 8, 18–31.
[25]	Buettner, C.; Rippberger, M.J.; Smith, J.K.; Leveille, S.G.; Davis, R.B.; Mittleman, M.A. Statin use and musculoskeletal pain among adults with and without arthritis. Am. J. Med. 2012, 125, 176–182.
[26]	Sharma, N.; Cooper, R.; Kuh, D.; Shah, I. Publisher Correction: associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort. Sci. Rep. 2018, 8, 3579.
[27]	Morioka, T.Y.; Lee, A.J.; Bertisch, S.; Buettner, C. Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study. Atherosclerosis. 2015, 238, 77–82.

补充维生素D对代谢综合征的影响: 一项回顾性研究

Effect of vitamin D supplementation on metabolic syndrome: a retrospective study

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 3

参考文献 27

相关文章 3

编辑推荐

Metrics

本文评价

[1]	都晓辉, 杨宏艳, 王涛, 崔红霞, 林宇, 李宏铃. 基于网络药理学和分子对接技术解读川皮苷改善代谢综合征的作用机制[J]. 中国药学(英文版), 2022, 31(11): 803-823.
[2]	辛健, 徐向楠, 王玉平, 张振涛, 马宇衡. PPAR激动剂的开发与应用[J]. 中国药学(英文版), 2018, 27(4): 215-228.
[3]	高玲燕, 马骁, 刘晓. 体内维生素功能的研究进展[J]. 中国药学(英文版), 2016, 25(5): 329-341.